Douglas Goetz
8Patents
2h-index
16Co-inventors
44Inventor score
Filing activity: Oct 12, 2001 → Jul 25, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7928132B2 | Methods for the amelioration of episodes of acute or chronic ulcerative colitis | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7182933B2 | Targeting drug/gene carriers to irradiated tissue | Human Necessities | 4 | Expired |
| US10023567B2 | Imidazole and thiazole compositions for modifying biological signaling | Emerging Cross-Sectional Technologies | 1 | Active |
| US10407420B2 | Imidazole and thiazole compositions for modifying biological signaling | Emerging Cross-Sectional Technologies | 0 | Active |
| US10392381B2 | Prevention and treatment of non-alcoholic fatty liver disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US9326972B2 | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression | Emerging Cross-Sectional Technologies | 0 | Active |
| US9750723B2 | Prevention and treatment of non-alcoholic fatty liver disease | Chemistry; Metallurgy | 0 | Active |
| US10633377B2 | Imidazole and thiazole compositions for modifying biological signaling | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.